New database aims to speed up FMT research for gut infections
NCT ID NCT03350711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study screens adults interested in fecal microbiota transplant (FMT) for Clostridium difficile infection. Researchers will collect medical information and run basic health tests to create a database of potential participants. The goal is to make it faster and easier to enroll people into future FMT studies. The study is currently suspended.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- fecal microbiota transplant (FMT)
- What this could lead to
- If successful, this screening database could help researchers quickly find eligible participants for future FMT studies, potentially speeding up development of treatments for C. diff infections.
- What could go wrong
- This is a screening study, not a treatment trial. It only creates a database; no direct health benefit is guaranteed. The study is currently suspended, so progress is on hold.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLOSTRIDIUM DIFFICILE INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory Clinic
Atlanta, Georgia, 30322, United States
-
Emory Hospital
Atlanta, Georgia, 30322, United States
-
The Hope Clinic of the Emory Vaccine Center
Decatur, Georgia, 30030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Engineered yeast pill takes on superbug c. diff in first human trial
- Should cancer patients get antibiotics for a dubious c. diff test? small trial seeks answers
- Poop pills? fecal transplants show promise for gut infections
- Poop pills? no, stool transplants aim to cure recurrent c. diff
- 4,000 patients join landmark poop transplant safety study
- Could a simple drink help clear confusion in hospitalized seniors?